AnaptysBio Share Price

AnaptysBio Share Price

NASDAQ: ANAB | Small Cap | Healthcare
$46.65
-$0.76 (-1.6%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

AnaptysBio Stock Performance

Open
$47.48
Prev. Close
$47.41
Circuit Range
N/A
Day Range
$46.35 - $47.69
Year Range
$33.69 - $72.93
Volume
20,100
Average Traded
$46.79

AnaptysBio Share Price Today

As of 22 November 2026, AnaptysBio, Inc.'s share price is $46.65. The stock opened at $47.48, compared to its previous close of $47.41. During today's trading session, AnaptysBio, Inc.'s share price traded between $46.35 and $47.69, with an average price of $47.02. Over the past 52 weeks, the stock has recorded a high of $72.93 and a low of $33.69. In terms of performance, AnaptysBio, Inc.'s share price has declined by 16.32% over the last six months and is up 11.60% on a year-on-year basis.

AnaptysBio Share Price Chart

Line chart of the AnaptysBio price trend over the selected period. The price fell overall, ranging from 46.29 to 47.77, ending at 46.65.
$46.35$47.69
L
Show Current Price
H

AnaptysBio Stock Fundamentals & Key Indicators

Market Cap
$1.34B
PE Ratio (TTM)
16.56
Dividend Yield
0.00%
EPS (TTM)
$2.82
Revenue (TTM)
$234.60B
Return On Equity (TTM)
402.09%
Profit Margin
-5.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-74.32%

AnaptysBio Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Sep 2025Sep 2026
Revenue$76.32$108.25$76.32$30.27
Net Profit$15.11$49.61$15.11$3.88
Net Profit Margin19.80%45.83%19.80%12.82%
Income ChangeN/A228.33%-69.54%-74.32%

AnaptysBio Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$10.29$17.16$91.28$234.60
Net Profit-$128.72-$163.62-$145.23-$13.23
Net Profit Margin-1250.92%-953.50%-159.10%-5.64%
Income ChangeN/A-27.11%11.24%90.89%

AnaptysBio Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets118.5614.1551.9645.55
Current Assets198.43350.25431.88406.84
Total Assets316.98364.4483.83452.39
Non Current Liabilities271.05288.56367.54326.84
Current Liabilities35.3538.6345.4337.44
Total Liabilities306.4327.19412.97364.29
Shareholders' Equity10.5937.2170.8788.1

AnaptysBio Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating19.7-135.34-120.8-73.59
Investing228.0395.4144.75-394.85
Financing-132.61127.05-59.344.02

About AnaptysBio

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

AnaptysBio Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$48.11
$46.51
-3.69%
Oct 2026
$50.98
$48.29
-4.16%
Sep 2026
$56.96
$50.38
-12.09%
Aug 2026
$51.98
$57.31
+7.57%
Jul 2026
$66.59
$53.28
-21.01%
Jun 2026
$54.54
$67.45
+21.01%
May 2026
$66.31
$55.74
-15.21%
Apr 2026
$56.16
$65.74
+18.40%
Mar 2026
$54.22
$55.52
+1.06%
Feb 2026
$47.86
$54.94
+15.88%
Jan 2026
$48.57
$47.41
-2.24%
Dec 2025
$41.94
$48.49
+16.03%

AnaptysBio Share Price FAQs